       Document 0002
 DOCN  M9630002
 TI    [Viral hepatitis C in chronic hemodialyzed patients in southern Tunisia.
       Prevalence and risk factors]
 DT    9603
 AU    Hachicha J; Hammami A; Masmoudi H; Ben Hmida M; Karray H; Kharrat M;
       Kammoun F; Jarraya A; Service de Medecine Interne. CHU, Sfax, Tunisie.
 SO    Ann Med Interne (Paris). 1995;146(5):295-8. Unique Identifier : AIDSLINE
       MED/96099553
 AB    To define, the prevalence and risk factors of hepatitis C virus (HCV) a
       prospective and multicentre study was performed in 235 patients
       undergoing haemodialysis, the anti-HCV antibodies were evaluated using
       an immuno-enzymatic method (wellcozyme anti-HCV). The following
       parameters were obtained for all patients: time on haemodialysis, blood
       transfusion, liver enzymes (ALT, AST), others virus markers: HBV (HBs
       Ag, HBs Ab, HBc Ab) and HIV. Anti-HCV was positive in 86 patients (42%).
       There was a significant (p < 0.05) relationship between presence of
       anti-HCV antibodies and duration of haemodialysis (33 +/- 24 vs 20 +/-
       19 months). No statistically significant difference was found with blood
       transfusion and the others parameters. In conclusion, the prevalence of
       HCV in our center of dialysis was high. The duration of dialysis seems
       to be the main risk factor.
 DE    Cross Infection/PREVENTION & CONTROL  English Abstract  Female
       Hemodialysis/*ADVERSE EFFECTS  Hemodialysis Units, Hospital  Hepatitis
       C/EPIDEMIOLOGY/*ETIOLOGY/PREVENTION & CONTROL  Human  Male  Middle Age
       Prevalence  Prospective Studies  Risk Factors  Tunisia/EPIDEMIOLOGY
       JOURNAL ARTICLE  MULTICENTER STUDY

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

